/
QSI
$0.89+$0.03 (+3.99%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$186.1M
218M shares
52-week range
$0.69 – $3.10
8% from low
Sector
MEASURING & CONTROLLING DEVICES, NEC
Exchange
NASDAQ
CS
Borrow rate
1.77%
Moderate
Price (6 mo)
Loading chart…
Change$-11.17
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $1.1M | $3.1M | $2.4M |
| Cost of revenue | $0 | $0 | $0 | $0 | $594.0K | $1.5M | $1.3M |
| Gross profit | $0 | $0 | $0 | $0 | $488.0K | $1.6M | $1.2M |
| Gross margin | — | — | — | — | 45.1% | 52.3% | 47.3% |
| R&D | $28.1M | $27.6M | $46.6M | $72.1M | $67.0M | $59.6M | $53.8M |
| Operating income | −$36.6M | −$36.7M | −$96.9M | −$123.8M | −$111.2M | −$108.6M | −$97.4M |
| EBITDA | −$35.8M | −$35.8M | −$93.9M | −$111.8M | −$91.8M | −$96.4M | −$92.9M |
| Net income | −$35.8M | −$36.6M | −$95.0M | −$132.4M | −$96.0M | −$101.0M | −$101.3M |
| Net margin | — | — | — | — | -8868.8% | -3303.0% | -4160.1% |
| EPS (diluted) | -0.26 | -6.81 | -1.19 | -0.95 | -0.68 | -0.71 | -0.51 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1M | $-0.43 | $-0.54–$-0.32 | 1 |
| 2027 | $10M | $-0.40 | $-0.49–$-0.29 | 1 |
| 2028 | $28M | $-0.31 | $-0.35–$-0.28 | 3 |
| 2029 | $66M | $-0.21 | $-0.26–$-0.15 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.10
Price
$0.89
Implied downside
-89%
Peer comparison
Quantum-Si Incorporated Class A Common Stock
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
www.quantum-si.com- Employees
- 145
- IPO / List date
- Jun 11, 2021
- HQ
- BRANFORD, CT
Held by traders on TradeandTell
No one on the platform currently holds QSI.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 117,900 | $91.3K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded QSI yet.
